The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes
Authors
Keywords
-
Journal
Therapeutic Advances in Gastroenterology
Volume 9, Issue 4, Pages 503-512
Publisher
SAGE Publications
Online
2016-05-23
DOI
10.1177/1756283x16647935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis
- (2016) Gaik W. Tew et al. GASTROENTEROLOGY
- Complications of biologics in inflammatory bowel disease
- (2015) Paula Sousa et al. CURRENT OPINION IN GASTROENTEROLOGY
- Integrins and adhesion molecules as targets to treat inflammatory bowel disease
- (2015) Ivana Bravatà et al. CURRENT OPINION IN PHARMACOLOGY
- Biological Agents for Moderately to Severely Active Ulcerative Colitis
- (2014) Silvio Danese et al. ANNALS OF INTERNAL MEDICINE
- Development of Drugs to Target Interactions Between Leukocytes and Endothelial Cells and Treatment Algorithms for Inflammatory Bowel Diseases
- (2014) Silvio Danese et al. GASTROENTEROLOGY
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease – an update
- (2013) Monica Cesarini et al. Expert Review of Clinical Immunology
- Etrolizumab: Anti-β7—A Novel Therapy for Ulcerative Colitis
- (2013) Kirk K. Lin et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy
- (2011) S. Danese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
- (2011) Saskia Thomas et al. INFLAMMOPHARMACOLOGY
- Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease
- (2010) Gionata Fiorino et al. Expert Review of Clinical Immunology
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started